Committee hears broad support for bill to require insurance coverage of biomarker testing
Testimony at the Aging Committee public hearing backed HB 6771 to require coverage for biomarker testing, with patients, clinicians and advocacy groups saying earlier, evidence‑based testing improves diagnosis and treatment options for cancer and dementia. Witnesses urged narrowly tailored coverage rules and cost safeguards.
The full story
State Senator Jeff Gordon and a range of patients, clinicians and advocacy groups told the Aging Committee on Feb. 20 that House Bill 6771, which would require private insurers to cover biomarker testing when medically appropriate, could speed diagnosis and expand access to personalized treatments.
Sign up to keep reading.
Your free newsletter brings you what your city council, county, and school board discussed and decided.
or